These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 1128746)

  • 1. The present status of radical prostatectomy for stages A and B prostatic cancer.
    Jewett HJ
    Urol Clin North Am; 1975 Feb; 2(1):105-24. PubMed ID: 1128746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient selection for, results of, and impact on tumor resection of potency-sparing radical prostatectomy.
    Catalona WJ
    Urol Clin North Am; 1990 Nov; 17(4):819-26. PubMed ID: 2219579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Incidental prostate cancer: volume, location and degree of differentiation of the tumor in the radical prostatectomy specimen and value of subclassification to stage A1 and A2].
    Voges GE; McNeal JE; Stamey TA
    Urologe A; 1991 Nov; 30(6):401-9. PubMed ID: 1722922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Early results following radical prostatectomy in patients with capsule invasion, seminal vesicle infiltration and micrometastases].
    Terhorst B; Friedrichs R
    Urologe A; 1990 Mar; 29(2):91-5. PubMed ID: 2330669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histopathological prostate cancer characteristics at radical prostatectomy after population based screening.
    Hoedemaeker RF; Rietbergen JB; Kranse R; Schröder FH; van der Kwast TH
    J Urol; 2000 Aug; 164(2):411-5. PubMed ID: 10893598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salvage radical prostatectomy: outcome measured by serum prostate specific antigen levels.
    Rogers E; Ohori M; Kassabian VS; Wheeler TM; Scardino PT
    J Urol; 1995 Jan; 153(1):104-10. PubMed ID: 7526002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A survey of radical surgery without neoadjuvant therapy for patients with stage B and C prostatic carcinoma].
    Matsuzaki J; Kanda F; Watanabe T; Ouchi H; Tsuchiya F; Fukuda M; Satomi Y
    Hinyokika Kiyo; 2001 Jan; 47(1):5-10. PubMed ID: 11235223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Has there been a recent shift in the pathological features and prognosis of patients treated with radical prostatectomy?
    Soh S; Kattan MW; Berkman S; Wheeler TM; Scardino PT
    J Urol; 1997 Jun; 157(6):2212-8. PubMed ID: 9146618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extended experience with radical prostatectomy for clinical stage T3 prostate cancer: outcome and contemporary morbidity.
    Lerner SE; Blute ML; Zincke H
    J Urol; 1995 Oct; 154(4):1447-52. PubMed ID: 7658555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Results of 15 years of radical prostatectomy].
    Frohmüller H; Theiss M; Wirth M; Hofmockel G
    Urologe A; 1995 May; 34(3):225-30. PubMed ID: 7610518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term hazard of progression after radical prostatectomy for clinically localized prostate cancer: continued risk of biochemical failure after 5 years.
    Amling CL; Blute ML; Bergstralh EJ; Seay TM; Slezak J; Zincke H
    J Urol; 2000 Jul; 164(1):101-5. PubMed ID: 10840432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathological parameters of radical prostatectomy for clinical stages T1c versus T2 prostate adenocarcinoma: decreased pathological stage and increased detection of transition zone tumors.
    Jack GS; Cookson MS; Coffey CS; Vader V; Roberts RL; Chang SS; Smith JA; Shappell SB
    J Urol; 2002 Aug; 168(2):519-24. PubMed ID: 12131301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved clinical staging system combining biopsy laterality and TNM stage for men with T1c and T2 prostate cancer: results from the SEARCH database.
    Freedland SJ; Presti JC; Terris MK; Kane CJ; Aronson WJ; Dorey F; Amling CL;
    J Urol; 2003 Jun; 169(6):2129-35. PubMed ID: 12771734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical outcome of radical prostatectomy for stage C prostate cancer: comparison with other treatment modalities].
    Maeda O; Meguro N; Saiki S; Kinouchi T; Kuroda M; Usami M; Kotake T
    Hinyokika Kiyo; 1997 Jun; 43(6):457-60. PubMed ID: 9250499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Radical prostatectomy in cancer of the prostate. Preliminary adjuvant therapy and previous considerations].
    Villanueva Benedicto A; Caro Cebrián C; Liédana Torres JM; González Enguita C; Rodríguez Vela L; Rioja Sanz C; Rioja Sanz LA
    Arch Esp Urol; 1989; 42 Suppl 2():141-53. PubMed ID: 2639619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. External beam radiotherapy versus radical prostatectomy for clinical stage T1-2 prostate cancer: therapeutic implications of stratification by pretreatment PSA levels and biopsy Gleason scores.
    Kupelian P; Katcher J; Levin H; Zippe C; Suh J; Macklis R; Klein E
    Cancer J Sci Am; 1997; 3(2):78-87. PubMed ID: 9099457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of endocrine therapy in the management of local and distant recurrence of prostate cancer following radical prostatectomy or radiation therapy.
    Mayer FJ; Crawford ED
    Urol Clin North Am; 1994 Nov; 21(4):707-15. PubMed ID: 7974899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Limited pelvic lymph node dissection at the time of radical prostatectomy does not affect 5-year failure rates for low, intermediate and high risk prostate cancer: results from CaPSURE.
    Berglund RK; Sadetsky N; DuChane J; Carroll PR; Klein EA
    J Urol; 2007 Feb; 177(2):526-29; discussion 529-30. PubMed ID: 17222625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical stage T3 prostate cancer: natural history, therapeutic choices and their results].
    Peneau M; Piéchaud T; Cariou G; Ragni E; Fontaine E; Fournier G
    Prog Urol; 1998 Dec; 8(6):977-93. PubMed ID: 9894256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of early adjuvant hormonal therapy after radical prostatectomy for prostate cancer.
    Zincke H; Lau W; Bergstralh E; Blute ML
    J Urol; 2001 Dec; 166(6):2208-15. PubMed ID: 11696737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.